Shopping Cart
- Remove All
- Your shopping cart is currently empty
Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $372 | 7-10 days | |
5 mg | $953 | 7-10 days | |
10 mg | $1,570 | 7-10 days |
Description | Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity. |
Alias | STI571 D8, CGP-57148B D8 |
Molecular Weight | 501.65 |
Formula | C29H31N7O |
Cas No. | 1092942-82-9 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.